T. J. Vries

发表

Ae2a,b‐Deficient mice exhibit osteopetrosis of long bones but not of calvaria

F. Lecanda, S. Kellokumpu, V. Everts, 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Vitamin B12 Deficiency Stimulates Osteoclastogenesis via Increased Homocysteine and Methylmalonic Acid

H. Blom, R. Dhonukshe-Rutten, Michael Müller, 2009, Calcified Tissue International.

CHAPTER 6 The involvement of M-CSF and RANKL in mitochondrial biogenesis during osteoclast formation and macrophage differentiation

V. Bloemen, V. Everts, I. Jansen, 2010 .

Lysosomal-associated membrane protein-2 (LAMP-2) is involved in osteoblast-induced osteoclastogenesis

P. Saftig, V. Everts, W. Tigchelaar-Gutter, 2015 .

Inhibitory regulation of osteoclast bone resorption by SIRP α

G. Langenbach, T. Matozaki, T. Schoenmaker, 2011 .

CHAPTER 5 Migration dynamics of osteoclasts and their precursors during differentiation

V. Bloemen, V. Everts, I. Jansen, 2010 .

Osteoclast precursors from different bone sites respond differently to IL-1β

V. Everts, T. J. Vries, Ineke D.C.Jansen, 2015 .

Myeloid blasts are the mouse bone marrow cells prone to differentiate into osteoclasts

V. Everts, T. Schoenmaker, P. Leenen, 2009, Journal of leukocyte biology.

A Systematic Review of the Evidence of Hematopoietic Stem Cell Differentiation to Fibroblasts

D. Micha, R. D. Vries, R. de Vries, 2022, Biomedicines.

lethally progressive osteopetrosis in oc/oc mice targeted neonatal gene therapy reverses - Hematopoietic stem cell

S. Karlsson, M. Ehinger, J. Richter, 2013 .

Osteoclast Formation from Peripheral Blood of Patients with Bone-lytic Diseases

V. Everts, T. J. Vries, 2009 .

Localization of the components of the plasminogen activation system in cutaneous melanocytic lesions — a minireview

U. Weidle, D. Ruiter, G. Muijen, 1996 .

UvA-DARE ( Digital Academic Repository ) Prevention and treatment of peri-implant diseases Cleaning of titanium dental implant surfaces

T. Schoenmaker, T. J. Vries, G. A. Weijden, 2017 .

UvA-DARE ( Digital Academic Repository ) Prevention and treatment of peri-implant diseases

T. Schoenmaker, T. J. Vries, G. A. Weijden, 2017 .

Transcription factor C/EBPb isoform ratio regulates osteoclastogenesis through MafB This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits distribution,andreproductioninanymedium,providedtheoriginalauthorandsourcearecredited.Thislicensed

A. Leutz, E. Sterneck, T. Schoenmaker, 2009 .

TETRANECTIN AND PLASMIN/PLASMINOGEN ARE SIMILARLY DISTRIBUTED AT THE INVASIVE FRONT OF CUTANEOUS MELANOMA LESIONS

T. J. Vries, K. Rutter, IT PETERE.J.DEW, 2020 .

Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood

C. Punt, D. Ruiter, G. Muijen, 1999, British Journal of Cancer.

CHAPTER 4 IL-1 β favors osteoclastogenesis via the supporting fibroblasts

V. Bloemen, V. Everts, T. Schoenmaker, 2010 .

UvA-DARE ( Digital Academic Repository ) Monocyte heterogeneity

V. Everts, Sara Sprangers, T. J. Vries, 2016 .

IL‐1β differently stimulates proliferation and multinucleation of distinct mouse bone marrow osteoclast precursor subsets

V. Everts, P. Leenen, I. Jansen, 2016, Journal of leukocyte biology.

Inhibitory regulation of osteoclast bone resorption by signal regulatory protein α

Georg Kraal, Ton Schoenmaker, Vincent Everts, 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Zoledronic acid differently affects long bone and jaw bone turnover and induces molar root resorption in female mice

V. Everts, M. A. Duin, I. Jansen, 2014 .

The effect of bisphosphonates on human periodontal-ligament-fibroblast-mediated osteoclastogenesis

V. Everts, T. Forouzanfar, T. Schoenmaker, 2014 .

The plasminogen activation system in melanocytic tumors

T. J. Vries, 1996 .

' s personal copy Osteocytes subjected to fluid flow inhibit osteoclast formation and bone resorption

A. Kuijpers-Jagtman, J. Klein-Nulend, V. Everts, 2007 .

Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.

P. Quax, H. Verspaget, U. Weidle, 1994, The American journal of pathology.

Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.

T. Wobbes, G. V. van Muijen, D. Ruiter, 1997, Cancer research.

Role of periodontal ligament fibroblasts in osteoclastogenesis: a review.

V. Everts, T. D. de Vries, T. J. Vries, 2015, Journal of periodontal research.

Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines.

A. V. van Kessel, G. Adema, G. V. van Muijen, 2000, Cancer research.

Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.

W. Silvers, B. Mintz, T. D. de Vries, 1995, Cancer research.

IL‐1β differently stimulates proliferation and multinucleation of distinct mouse bone marrow osteoclast precursor subsets

V. Everts, P. Leenen, I. Jansen, 2016, Journal of leukocyte biology.

VU Research Portal Functional differences between site-specific osteoclasts

F. Lecanda, T. Schoenmaker, I. Jansen, 2015 .

Expression of immunotherapy candidate proteins GP100, Mart-1/Melan-A and tyrosinase in human melanocytic lesions and melanoma cell lines: 497

D. Ruiter, T. J. Vries, A. Fourkour, 1997 .

Melanocytic Tumor Progression Receptor-associated Protein in Late Stages of Cutaneous-Macroglobulin Receptor and Its 2 α Receptor-related Protein / Decreased Expression of Both the Low-Density Lipoprotein Updated

U. Weidle, D. Ruiter, J. Verheijen, 2006 .